The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...

(CNN/CNN NEWSOURCE/WKRC) - The Food and Drug Administration has approved Lynkuet, a new non-hormonal pill designed to relieve ...

The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after ...

Tim Curry’s wry humor was on full display at rare appearance for 50th anniversary screening of ‘Rocky Horror Picture Show’ Cardiologist: 9 American foods you 'couldn't pay me to eat'—after 20 years of ...

And so I rattled off some of my many ailments: horrible headaches, crippling fatigue or insomnia, heart palpitations, anxiety ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood of worsening disease when added within ...

A large new study found that the side effects of antidepressants vary significantly by drug. Some medications resulted in weight loss, while others resulted in weight gain. Heart rate and blood ...

Sept 30 (Reuters) - The U.S. Food and Drug Administration has approved Novartis' (NOVN.S), opens new tab oral treatment for patients with type of chronic inflammatory skin disease, the Swiss drugmaker ...

President Donald Trump has labeled drug cartels operating in the Caribbean as “unlawful combatants” and said the U.S. is engaged in an “armed conflict,” multiple outlets reported Thursday, following ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...